CATEGORIES
![ABB and B&R launch first fully integrated Machine-Centric Robotics solution ABB and B&R launch first fully integrated Machine-Centric Robotics solution](https://reseuro.magzter.com/100x125/articles/5843/408084/5e39411729ffe/crp_ABB-and-BR-launch-first-fully-integrated-Machine-Centric-Robotics-solution.jpg)
ABB and B&R launch first fully integrated Machine-Centric Robotics solution
Fully integrating ABB’s robots into its automation systems means that B&R will now be able to supply machine builders with machine automation and robotics from a single source
!['To harness the full value of digital transformation there must be a structured methodology in place' 'To harness the full value of digital transformation there must be a structured methodology in place'](https://reseuro.magzter.com/100x125/articles/5843/408084/5e3940097cee2/crp_To-harness-the-full-value-of-digital-transformation-there-must-be-a-structured-methodology-in-place.jpg)
'To harness the full value of digital transformation there must be a structured methodology in place'
Cybage Software, a global technology consulting organisation is partnering with the life sciences organisation to spur a enterprise-wide digital transformation. Vivek Vig, Vice President – Healthcare and Life Sciences, Cybage Software outlines how IT and digital technologies will be crucial for progress in this sector and details how to harness the full value of these transformational technolgies and the role that Cybage can play in this tech-driven era, in an exclusive interaction with Lakshmipriya Nair
![E-Pharmacies – What Lies Ahead? E-Pharmacies – What Lies Ahead?](https://reseuro.magzter.com/100x125/articles/5843/402476/5e200b85018fb/crp_E-pharmacies-what-lies-ahead.jpg)
E-Pharmacies – What Lies Ahead?
Dr Vikram A Munshi, Founder,WhiteSpace, Consulting and Capability Building discusses how e-pharmacies are faring in current times, their growth potential, and what their future beholds
![Lonza India plans to double its turnover by 2024 Lonza India plans to double its turnover by 2024](https://reseuro.magzter.com/100x125/articles/5843/402476/5e200a4a6cb9e/crp_Lonza-India-plans-to-double-its-turnover-by-2024.jpg)
Lonza India plans to double its turnover by 2024
Lonza is a global integrated solutions provider for pharma, consumer healthcare, and nutrition segments. Deepak Sood, MD, Lonza India talks about the company's plans for the Indian market, its strategic focus areas, and more in an exclusive interview with Express Pharma
![RARE DISEASES AWAITING RENEWED FOCUS RARE DISEASES AWAITING RENEWED FOCUS](https://reseuro.magzter.com/100x125/articles/5843/402476/5e2007fac8a5f/crp_RARE-DISEASES-AWAITING-RENEWED-FOCUS.jpg)
RARE DISEASES AWAITING RENEWED FOCUS
India needs to make significant investments in R&D, policy reforms, and measures to enable affordability and accessibility of medicines and healthcare to manage the burden posed by rare diseases
![Atul Kumar Nasa awarded 'Schroff Memorial National Award, 2019' Atul Kumar Nasa awarded 'Schroff Memorial National Award, 2019'](https://reseuro.magzter.com/100x125/articles/5843/402476/5e200d11428e6/crp_Atul-Kumar-Nasa-awarded-Schroff-Memorial-National-Award-2019.jpg)
Atul Kumar Nasa awarded 'Schroff Memorial National Award, 2019'
The award was given by the Indian Hospital Pharmacists’Association in recognition of his contribution in strengthening the regulatory services
![‘We may look at scaling to 50 per cent growth in the next financial year' ‘We may look at scaling to 50 per cent growth in the next financial year'](https://reseuro.magzter.com/100x125/articles/5843/402476/5e20098a1604d/crp_We-may-look-at-scaling-to-50-per-cent-growth-in-the-next-financial-year.jpg)
‘We may look at scaling to 50 per cent growth in the next financial year'
Manish Jain, Managing Director of Cilicant Chem, a company that provides solutions to protect highly moisture-sensitive products from the harmful effects of moisture or humidity for the desiccant market, discusses the company's growth strategy with Akanki Sharma
![Ami Polymer signs master distribution agreement with Foxx Life Sciences Ami Polymer signs master distribution agreement with Foxx Life Sciences](https://reseuro.magzter.com/100x125/articles/5843/402476/5e200c2b7b828/crp_Ami-Polymer-signs-master-distribution-agreement-with-Foxx-Life-Sciences.jpg)
Ami Polymer signs master distribution agreement with Foxx Life Sciences
The Network allows full coverage of specialised Pharma Tubings (Platinum cured Silicone, TPE, FKM, and FEP tubings), O-rings, Manifolds, and Sanitary Gaskets for the markets such as Bio pharma, Medical and Lifesciences
![Piramal Swasthya and The Rockefeller Foundation announce partnership to accelerate India's public health transformation Piramal Swasthya and The Rockefeller Foundation announce partnership to accelerate India's public health transformation](https://reseuro.magzter.com/100x125/articles/5843/397454/5e0af04d91ddc/crp_Piramal-Swasthya-and-The-Rockefeller-Foundation-announce-partnership-to-accelerate-Indias-public-health-transformation.jpg)
Piramal Swasthya and The Rockefeller Foundation announce partnership to accelerate India's public health transformation
Collaboration will harness innovative digital technology to support the Government of India’s vision to provide quality healthcare for all
![UNLOCKING POTENTIAL UNLOCKING POTENTIAL](https://reseuro.magzter.com/100x125/articles/5843/397454/5e0adfdb5e035/crp_UNLOCKING-POTENTIAL.jpg)
UNLOCKING POTENTIAL
Experts outline plans of action for capability expansion, reforms and market leadership to step up India Pharma Inc's growth trajectory
![Nutraceuticals is the fastest-growing segment of the biopharmaceutical industry in India Nutraceuticals is the fastest-growing segment of the biopharmaceutical industry in India](https://reseuro.magzter.com/100x125/articles/5843/397454/5e0aef030c6d0/crp_Nutraceuticals-is-the-fastest-growing-segment-of-the-biopharmaceutical-industry-in-India.jpg)
Nutraceuticals is the fastest-growing segment of the biopharmaceutical industry in India
As a biopharma company, we realise that the most critical aspect is to provide wellresearched and developed products, which are cost-effective and can be accessed by all, informs Gaurav Kaushik, Managing Director and CEO, Meteoric Biopharmaceuticals, to Akanki Sharma
![7th Annual CubeX-Nicholas Hall Consumer Healthcare Conference 2019 held 7th Annual CubeX-Nicholas Hall Consumer Healthcare Conference 2019 held](https://reseuro.magzter.com/100x125/articles/5843/397454/5e0aed314e7ed/crp_7th-Annual-CubeX-Nicholas-Hall-Consumer-Healthcare-Conference-2019-held.jpg)
7th Annual CubeX-Nicholas Hall Consumer Healthcare Conference 2019 held
The conference explored ways for marketers to connect with today’s tech-savvy consumers through speakers who were presented at the conference
![71st Indian Pharmaceutical Congress held in Chennai 71st Indian Pharmaceutical Congress held in Chennai](https://reseuro.magzter.com/100x125/articles/5843/397454/5e0ae371a8ec8/crp_71st-Indian-Pharmaceutical-Congress-held-in-Chennai.jpg)
71st Indian Pharmaceutical Congress held in Chennai
The three-day conference saw the participation of pharmaceutical experts, regulators, academicians and pharmacy students from across the country. Industry stakeholders were also able to showcase their innovations at an exhibition that was organised alongside the conference By Akanki Sharma
![Patient-Centric Innovation – Catering To Future Needs Patient-Centric Innovation – Catering To Future Needs](https://reseuro.magzter.com/100x125/articles/5843/393497/5e09888c16e36/crp_Patient-Centric-Innovation-Catering-To-Future-Needs.jpg)
Patient-Centric Innovation – Catering To Future Needs
Manoj Saxena, Managing Director, Bayer Zydus Pharma, talks about how technology has become an essential tool that complements the personal and physical interaction with a healthcare professional to help patients lead a healthier life
![Routine Pneumococcal Vaccination Rates Remain High In Children, But Subpar In Elderly: Globaldata Report Routine Pneumococcal Vaccination Rates Remain High In Children, But Subpar In Elderly: Globaldata Report](https://reseuro.magzter.com/100x125/articles/5843/393497/5e098c326b145/crp_Routine-Pneumococcal-Vaccination-Rates-Remain-High-In-Children-But-Subpar-In-Elderly-Globaldata-Report.jpg)
Routine Pneumococcal Vaccination Rates Remain High In Children, But Subpar In Elderly: Globaldata Report
The company’s latest report,‘Pneumococcal Vaccines: Epidemiology Forecast to 2028’, reveals that the average pediatric pneumococcal vaccination rates in the combined 7MM are expected to marginally change from 85.98 per cent in 2018 to 85.12 per cent in 2028
![SCHOTT Glass Strenghtens India Facility As Asian Hub SCHOTT Glass Strenghtens India Facility As Asian Hub](https://reseuro.magzter.com/100x125/articles/5843/393497/5e098d3f4718b/crp_SCHOTT-Glass-Strenghtens-India-Facility-As-Asian-Hub.jpg)
SCHOTT Glass Strenghtens India Facility As Asian Hub
With investments of close to €47 million in India over two years, global pharmaceutical glass manufacturer SCHOTT AG clearly sees the country as a vital cog in its global strategy. Georg Sparschuh, MD, SCHOTT Glass India and Dr Patrick Markschläger, Executive VP, SCHOTT AG, Business Unit Tubing reveal the company's strategy to build India into an Asian hub for SCHOTT pharma tubing, their endeavours to be as sustainable as posssible and how investing in the futures of the communities in which their manufacturing plants are based is simply good business practice
![Bombay College Of Pharmacy Receives FICCI Award For Excellence In Research Bombay College Of Pharmacy Receives FICCI Award For Excellence In Research](https://reseuro.magzter.com/100x125/articles/5843/393497/5e0992a733075/crp_Bombay-College-Of-Pharmacy-Receives-FICCI-Award-For-Excellence-In-Research.jpg)
Bombay College Of Pharmacy Receives FICCI Award For Excellence In Research
The award was received by Prof Krishnapriya Mohanraj, in-charge Principal, from Union Transport Minister Nitin Gadkari
![‘We Consider The Ever-evolving Needs Of The Industry As An Opportunity To Do More And Serve Better' ‘We Consider The Ever-evolving Needs Of The Industry As An Opportunity To Do More And Serve Better'](https://reseuro.magzter.com/100x125/articles/5843/393497/5e099072365e7/crp_We-Consider-The-Ever-evolving-Needs-Of-The-Industry-As-An-Opportunity-To-Do-More-And-Serve-Better.jpg)
‘We Consider The Ever-evolving Needs Of The Industry As An Opportunity To Do More And Serve Better'
Ashok Kumar Prusty, Executive Vice President, Bry-Air reveals more about hi company’s offerings for the pharma sector, in an interaction with Sanjiv Das
![Biocon Appoints Siddharth Mittal As Its CEO And Joint MD Biocon Appoints Siddharth Mittal As Its CEO And Joint MD](https://reseuro.magzter.com/100x125/articles/5843/393497/5e099221d74c1/crp_Biocon-Appoints-Siddharth-Mittal-As-Its-CEOAnd-Joint-MD.jpg)
Biocon Appoints Siddharth Mittal As Its CEO And Joint MD
He takes over from Dr Arun Chandavarkar who retired as Chief Executive Officer & Joint Managing Director of Biocon on November 30, 2019
![The Indian Pharmaceutical Industry: Pride And Growth Lever Of India The Indian Pharmaceutical Industry: Pride And Growth Lever Of India](https://reseuro.magzter.com/100x125/articles/5843/393497/5e09855c4780f/crp_The-Indian-Pharmaceutical-Industry-Pride-And-Growth-Lever-Of-India.jpg)
The Indian Pharmaceutical Industry: Pride And Growth Lever Of India
Sudarshan Jain, Secretary General, IPA and Archana Jatkar,Associate Secretary General, IPA reminisce on five significant steps which changed the course of India’s pharma industry and outline five steps that the industry needs to take for sustained growth over the next 25 years
![Augmenting India's Medical Arsenal: Genomicswill Facilitate Developing New-age Medicines Augmenting India's Medical Arsenal: Genomicswill Facilitate Developing New-age Medicines](https://reseuro.magzter.com/100x125/articles/5843/393497/5e098f097e2c1/crp_Augmenting-Indias-Medical-Arsenal-Genomicswill-Facilitate-Developing-New-age-Medicines.jpg)
Augmenting India's Medical Arsenal: Genomicswill Facilitate Developing New-age Medicines
Pranav Anam, Founder, The Gene Box explains how pharmacogenomics can create far reaching impact in the pharma industry such as addressing medicine wastage and establishing health equity
![IMCD Opens Three New Centres In India, China, Southeast Asia IMCD Opens Three New Centres In India, China, Southeast Asia](https://reseuro.magzter.com/100x125/articles/5843/393497/5e09915e9d9f3/crp_IMCDOpens-Three-New-Centres-In-India-China-Southeast-Asia.jpg)
IMCD Opens Three New Centres In India, China, Southeast Asia
The move adds to the company’s further expansion of global network in the Asia Pacific region
!['Patient-centric Marketing Will Become A Fundamental Pillar In The Future Of Pharma Marketing' 'Patient-centric Marketing Will Become A Fundamental Pillar In The Future Of Pharma Marketing'](https://reseuro.magzter.com/100x125/articles/5843/393497/5e098a610b7db/crp_Patient-centric-Marketing-Will-Become-A-Fundamental-Pillar-In-The-Future-Of-Pharma-Marketing.jpg)
'Patient-centric Marketing Will Become A Fundamental Pillar In The Future Of Pharma Marketing'
Sumita Mohapatro Pani, Senior General Manager, Lupin speaks to Viveka Roychowdhury on the rewriting of the pharma sales and marketing playbook in the past two decades and highlights what makes pharma brand positioning so unique
![Pregnant Women May Not Have Safety Risks With Common Travel Vaccines Pregnant Women May Not Have Safety Risks With Common Travel Vaccines](https://reseuro.magzter.com/100x125/articles/5843/389138/5de51e8001c6e/crp_Pregnant-women-may-not-have-safety-risks-with-common-travel-vaccines.jpg)
Pregnant Women May Not Have Safety Risks With Common Travel Vaccines
Researchers examined data from trials of common travel vaccines and found high-quality evidence that two - the flu vaccine and the Tdap vaccine (against tetanus, diphtheria and pertussis) - are safe for pregnant women and their babies
![“We expect to analyse patient safety data more quickly and detect trends” “We expect to analyse patient safety data more quickly and detect trends”](https://reseuro.magzter.com/100x125/articles/5843/389138/5de518b30c2f4/crp_We-expect-to-analyse-patient-safety-data-more-quickly-and-detect-trends.jpg)
“We expect to analyse patient safety data more quickly and detect trends”
With the introduction of SafeTrack tool, Bayer Zydus Pharma takes a step further in enhancing patient security. The tool allows patients, consumers, family, friends, caregivers and healthcare professionals to report side effects quickly. The company believes that good information is crucial for effective treatment. Manoj Saxena, Managing Director, Bayer Zydus Pharma discusses more about the web-based tool, SafeTrack, with Usha Sharma
![‘Lupin has gained significant momentum towards development of biosimilar products with primary focus on regulated markets' ‘Lupin has gained significant momentum towards development of biosimilar products with primary focus on regulated markets'](https://reseuro.magzter.com/100x125/articles/5843/389138/5de519be044d9/crp_Lupin-has-gained-significant-momentum-towards-development-of-biosimilar-products-with-primary-focus-on-regulated-markets.jpg)
‘Lupin has gained significant momentum towards development of biosimilar products with primary focus on regulated markets'
Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercializing biosimilars globally. The successful development of Etanercept biosimilar is a case in point. Dr Cyrus Karkaria, President-Biotechnology, Lupin divulges more details about the company’s projects in this arena, its focus areas, future plans of expansion and more, in an exclusive interview with Lakshmipirya Nair
![PURIFY'19 Conclave Shaping up to be a Landmark Event for Purification Chromatography PURIFY'19 Conclave Shaping up to be a Landmark Event for Purification Chromatography](https://reseuro.magzter.com/100x125/articles/5843/389138/5de51ccc0cda8/crp_PURIFY19-Conclave-Shaping-up-to-be-a-Landmark-Event-for-Purification-Chromatography.jpg)
PURIFY'19 Conclave Shaping up to be a Landmark Event for Purification Chromatography
This will be for the first time in India, where a conference, dedicated on chromatography purification will help stretch possibilities - be it discovery, development or scaleups
![Pinpoint secures new investment to develop ImpactAir Range Pinpoint secures new investment to develop ImpactAir Range](https://reseuro.magzter.com/100x125/articles/5843/389138/5de5162f17405/crp_Pinpoint-secures-new-investment-to-develop-ImpactAir-Range.jpg)
Pinpoint secures new investment to develop ImpactAir Range
Cherwell Laboratories and Development Bank of Wales (DBW) have both invested in Pinpoint and taken a minority share in the company's business
![Himalaya creates awareness about cleft in West Bengal Himalaya creates awareness about cleft in West Bengal](https://reseuro.magzter.com/100x125/articles/5843/389138/5de51b2b1627c/crp_Himalaya-creates-awareness-about-cleft-in-West-Bengal.jpg)
Himalaya creates awareness about cleft in West Bengal
The company has the launched the 'Ek Mutho Hanshi' cleft awareness campaign under its flagship initiative 'Muskaan', in partnership with Smile Train India
![FDA approves first treatment for inherited rare disease FDA approves first treatment for inherited rare disease](https://reseuro.magzter.com/100x125/articles/5843/389138/5de5172abac23/crp_FDA-approves-first-treatment-for-inherited-rare-disease.jpg)
FDA approves first treatment for inherited rare disease
The approval of the drug, Givlaari was based on the results of a clinical trial of 94 patients with acute hepatic porphyria